Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration
Diana Ferraro(Azienda Ospedaliero-Universitaria di Modena), Carlo Pozzilli(Sapienza University of Rome), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Girolama Alessandra Marfia(Erasmus University Rotterdam), Roberto Bergamaschi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Franco Granella(University of Parma), Roberto Balgera, Maria Cellerino(Ospedale Policlinico San Martino), E. Pisano(Federico II University Hospital), María Trojano(University of Bari Aldo Moro), Tommaso Guerra(University of Bari Aldo Moro), Carlo Avolio(University of Foggia), Massimiliano Mirabella(Università Cattolica del Sacro Cuore), Umberto Aguglia(Martin University), Davide Maimone(Ospedale Garibaldi), Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Ilaria Pesci, Raffaella Clerici(CTO Hospital), Simona Malucchi(Ospedale San Luigi Gonzaga), Luca Chiveri(Azienda Ospedaliera Ospedale Civile di Legnano), Alessia Di Sapio(Neuroscience Institute), Maria Pia Amato(University of Florence), Pietro Iaffaldano(University of Bari Aldo Moro), Sara Montepietra, Giovanna De Luca(University of Udine), Paola Banfi, Elisabetta Ferraro(IRCCS Ospedale San Raffaele), Damiano Paolicelli(University of Bari Aldo Moro), Matilde Inglese(New York University), Paola Cavalla, Paola Gazzola(University of Genoa), Simonetta Galgani(IRCCS San Camillo Hospital), Francesco Patti(University of Catania), Marco Capobianco(Ospedale San Luigi Gonzaga), Patrizia Sola(Azienda Ospedaliero-Universitaria di Modena), Francesca Vitetta(Azienda Ospedaliero-Universitaria di Modena), Giacomo Lus(University of Campania "Luigi Vanvitelli"), Alessandro Del Conte(University of Catania), Antonio Gallo(University of Campania "Luigi Vanvitelli"), Eleonora Cocco(University of Cagliari), Francesco Corea(Multiple Sclerosis Foundation), Vincenzo Brescia Morra(Federico II University Hospital), Giorgia Teresa Maniscalco(Ospedale Antonio Cardarelli), Elisabetta Cartechini(University of Macerata), P. Bellantonio(Istituto Neurologico Mediterraneo), C Paolo(University of Catania), Daniela Cargnelutti(Multiple Sclerosis Foundation), Maura Danni(Multiple Sclerosis Foundation), Maurizia Gatto(Ospedale Generale Regionale Francesco Miulli)
Cited by 10
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Multiple Sclerosis Severity Score
|Neurology|2005|959
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706